Left ventricular hypertrophy (LVH) is when the heart’s main pumping chamber, the left ventricle, becomes thicker and less able to pump blood efficiently. It usually develops because of another heart ...

BACKGROUND: Left ventricular hypertrophy (LVH) and prolonged QT interval at ECG (QTc) are common in both obesity and arterial hypertension (AH), and are risk factors for cardiovascular disease and ...

August 4, 2004 — In an era when the number of candidates for implantable cardioverter defibrillator (ICD) therapy continues to grow, identifying specific patients at risk for arrhythmic death -- the ...

Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in hypertensive left ventricular hypertrophy (HLVH) remains unclear. In a new study published in ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Human neutrophil peptide-1 (HNP-1) is a commonly investigated therapeutic agent. However, its role in ...

WHEN medical terminology was less precise the expression "strained heart" was employed at times to describe obscurely but ominously diseased hearts. This diagnosis is no longer made, but currently the ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

Previous research correlates high parathyroid hormone levels with left ventricular hypertrophy in patients with kidney failure. Total parathyroidectomy with forearm autotransplantation (tPTx+AT) may ...